Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0298009 Fused Pyrazole Derivatives As Kinase Inhibitors
A series of substituted pyrazolo[1,5-a]pyrimidine and pyrazolo[1,5-a][1,3,5]-triazine derivatives of formula (I), as defined herein, being selective inhibitors...
2018/0298008 PYRAZOLOPYRIMIDINE DERIVATIVES AS BTK INHIBITORS FOR THE TREATMENT OF CANCER
This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are...
2018/0298007 PYRAZOLO[1,5-A]TRIAZIN-4-AMINE DERIVATIVES USEFUL IN THERAPY
A compound of formula (I), or a pharmaceutically acceptable salt thereof, useful in therapy, in particular in the treatment of a viral infection. ##STR00001##
2018/0298006 Fused Tricyclic Imidazo Pyrazines as Modulators of TNF Activity
A series of substituted fused tricyclic imidazo pyrazine derivatives and analogues thereof, represented by formula (I), being potent modulators of human TNFa...
2018/0298005 PTERIDINE DERIVATIVES AS MODULATORS OF ROR GAMMA
The present invention encompasses compounds of formula (I) wherein the variables are defined herein which are suitable for the modulation of ROR.gamma. and the...
2018/0298004 ADENINE DERIVATIVES AND THEIR USE AS UV-PHOTOPROTECTIVE AGENTS
Adenine derivatives substituted at the C2, N6, and N9 purine positions having antisenescent and combined photoprotective UVA/UVB effects. These substances are...
2018/0298003 TETRACYCLIC BROMODOMAIN INHIBITORS
The present invention provides for compounds of formula (I) ##STR00001## wherein R1, R2, R6, Y1, Y2, Y3, A1, A2, A3, and A4 have any of the values defined in the...
2018/0298002 NICOTINIC ACETYLCHOLINE RECEPTOR SILENT AGONISTS
Derivatives of N,N-diethyl-N'-phenyl-piperazine, a silent agonist of the mammalian .alpha.7 nicotinic acetylcholine receptor, are provided. These silent...
2018/0298001 ERGOLINE COMPOUNDS AND USES THEREOF
Provided herein are ergoline compounds and pharmaceutical compositions thereof. In some embodiments, provided herein are methods of treatment, prevention, or...
2018/0298000 AMINOQUINOLINE COMPOUNDS HAVING ANTICANCER ACTIVITY
Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a...
2018/0297999 HISTONE DEMETHYLASE INHIBITORS
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted ...
2018/0297998 INTERMEDIATE COMPOUNDS FOR PREPARATION OF PRAZIQUANTEL AND PROCESSES FOR PREPARING THE INTERMEDIATE COMPOUNDS
Intermediate compounds for the preparation of Praziquantel are provided. In particular, the intermediate compounds provided include a compound of formula (IV)...
2018/0297997 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
Compounds of Formula (I) and methods of use as Janus kinase inhibitors are described herein.
2018/0297996 NON-SELECTIVE PROTEASE ACTIVATED RECEPTOR 4 ALA120THR ISOFORM ANTAGONIST
A substance of Formula (I) for use as a medicament for the treatment of cardiovascular diseases, wherein R is nitrogen or carbon; R.sup.1 is selected from the...
2018/0297995 PYRIMIDINE OR PYRIDOPYRIDONE COMPOUND AND APPLICATION THEREOF
The present invention discloses a pyrimidine or pyridopyridone compound as shown in formula (I) and an application thereof relating to the technical field of...
2018/0297994 POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC M2 RECEPTOR
The present application relates to positive allosteric modulators of the muscarinic M2 receptor, especially to novel 7-substituted ...
2018/0297993 EZH2 INHIBITORS AND USES THEREOF
The present disclosure provides compounds of any one of Formulae (I) and (II). The compounds described herein are inhibitors of histone methyltransferases...
2018/0297991 Novel Ferroportin Inhibitors
The invention relates to novel ferroportin inhibitors of the general formula (I) pharmaceutical compositions comprising them and the use thereof as...
2018/0297990 DOPAMINE D3 RECEPTOR ANTAGONISTS HAVING A MORPHOLINE MOIETY
The disclosure provides compounds of formula (I) or pharmaceutically acceptable salts thereof: The disclosure also provides processes for their preparation,...
2018/0297989 PROCESS FOR THE PREPARATION OF N-[4-[(3-CHLORO-4-FLUORO PHENYL) ...
The present invention relates to an improved process for the preparation of N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]ox- ...
2018/0297988 OXA SPIRO DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF IN MEDICINES
The present invention relates to an oxa spiro derivative, a preparation method therefor, and applications thereof in medicines. Particularly, the present...
2018/0297987 AMINO PYRIMIDINE SSAO INHIBITORS
The present invention provides compounds of the Formula (I), or a pharmaceutically acceptable salt thereof, where n and R1 are defined herein, methods of...
2018/0297986 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or...
2018/0297985 COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or...
2018/0297984 THERAPEUTIC INHIBITORY COMPOUNDS
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma...
2018/0297983 BENZOIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS
Compounds of formula (I): wherein X, Y, R.sub.1 and R.sub.3-R.sub.11 are as herein defined, and salts thereof are PAD4 inhibitors and may be useful in the...
2018/0297982 RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF
BA-1049 (R) and its active metabolite are disclosed. Also disclosed are pharmaceutical formulations containing BA-1049 (R) or its active metabolite.
2018/0297981 TRIAZOLE DERIVATIVESAS P2Y14 RECEPTOR ANTAGONISTS
Described are compounds, which are antagonists of the P2Y.sub.14 receptor, for example, a compound of formula (I) in which ring A, R.sup.1, R.sup.2, R.sup.3,...
2018/0297980 METHOD FOR PRODUCING HETEROCYCLIC COMPOUND
The present invention provides a production method of heterocyclic compound having an excellent CH24H inhibitory action, which is suitable for industrial...
2018/0297979 IMINO COMPOUNDS WITH A 2-CHLOROPYRIMIDIN-5-YL SUBSTITUENT AS PEST-CONTROL AGENTS
Provided herein are imino compounds of formula I ##STR00001## and stereoisomers, tautomers and salts thereof. Further provided herein are agricultural and...
2018/0297978 PYRAZINE COMPOUND AND ARTHROPOD PEST CONTROL AGENT CONTAINING SAME
Provided is a compound represented by formula (I): ##STR00001## or an N-oxide compound thereof, wherein the variable groups are as defined in the specification....
2018/0297977 Novel Pan-TAM Inhibitors And Mer/Axl Dual Inhibitors
This invention is in the area of improved therapeutic combinations for and methods of treating selected cancers using selected pyrimidine compounds having...
2018/0297976 GREEN OXIDATION CATALYTIC SYSTEM
Disclosed herein are reaction compositions comprising an oxidation catalyst, a solvent, and a substrate that is dissolved in the solvent. The oxidation...
2018/0297975 CYCLOHEXANE DERIVATIVE OR STEREOISOMER OR SALT THEREOF, AND PREPARATION AND USE THEREOF
Provided are a cyclohexane derivative as shown by formula IB or a stereoisomer or a salt thereof, and the preparation and use thereof. The cyclohexane...
2018/0297974 MOST EFFECTIVE PROCESS FOR BASE-FREE PREPARATION OF KETONE INTERMEDIATES USABLE FOR MANUFACTURE OF NEBIVOLOL
The invention relates to a process for the preparation of a ketone of a general formula 1 ##STR00001## with X being Cl or Br, in particular with X being Cl, with...
2018/0297973 Nitroalkene Trolox Derivatives and Methods of Use Thereof In The Treatment And Prevention of Inflammation...
The present invention is directed to a class of anti-inflammatory, antioxidant nitroalkene compounds used in biological or biochemical applications to reduce...
2018/0297972 METHOD FOR PRODUCING gamma-VALEROLACTONE
Provided is a method for producing .gamma.-valerolactone that is hard to elute metallic components and has high productivity. .gamma.-Valerolactone is...
2018/0297971 EPOXIDATION USING PEROXYGENASE
The invention relates to enzymatic methods for epoxidation of a non-cyclic aliphatic alkene, or a terpene.
2018/0297970 Acesulfame Potassium Compositions and Processes for Producing Same
Improved processes for producing high purity acesulfame potassium. In one embodiment, the process comprises the steps of contacting a solvent, e.g.,...
2018/0297969 Acesulfame Potassium Compositions and Processes for Producing Same
A process for producing acesulfame potassium, the process comprising the steps of providing a cyclizing agent composition comprising a cyclizing agent and a...
2018/0297968 Acesulfame Potassium Compositions and Processes for Producing Same
Compositions and processes for producing high purity acesulfame potassium are described. One process comprises the steps of forming a cyclic sulfur trioxide...
2018/0297967 Acesulfame Potassium Compositions and Processes for Producing Same
Compositions and processes for producing high purity acesulfame potassium are described. One process comprises the steps of providing a crude acesulfame...
2018/0297966 COMPOUNDS, COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME
Compounds are provided according to Formula (I), and hydrates thereof, and compositions thereof; and methods of using and making the same. Compounds of the...
2018/0297965 COMPOSITIONS AND METHODS FOR TREATING CANCERS
The invention describes compounds that inhibit both HDAC and GSK3.beta. (i.e., HDAC/GSK3.beta. dual inhibitors). The invention further describes compositions...
2018/0297964 NEW COMPOUNDS INHIBITORS OF THE YAP/TAZ-TEAD INTERACTION AND THEIR USE IN THE TREATMENT OF MALIGNANT MESOTHELIOMA
The invention relates to compounds of formula (I): ##STR00001## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are as defined in the...
2018/0297963 BROAD SPECTRUM ANTIVIRAL COMPOUNDS AND USES THEREOF
Disclosed herein, inter alia, are agents having antiviral activity and methods of use thereof.
2018/0297962 Heterocyclic Compounds Useful In The Treatment of Disease
Heterocyclic compounds are described that are lysophosphatidic acid receptor ligands that are useful in the treatment of lysophosphatidic acid...
2018/0297961 TETRAZOLE DERIVATIVES
The present invention relates to compounds of formula I ##STR00001## wherein R.sup.1' is CH.sub.3 R.sup.1 is methyl, ethyl, CF.sub.3, CH.sub.2OH, cyclopropyl or...
2018/0297960 DERIVATIVES OF 1,2,3-TRIAZOLYL CYCLOHEXAN-1-OL AND ITS USE
1,2,3-triazolyl cyclohexanol derivatives have been disclosed and their use as ligands accelerating the copper(I)-catalyzed azide-alkyne cycloaddition and the...
2018/0297959 BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF
The present invention belongs to the pharmaceutical field, and relates to a preparation method for a series of benzimidazole derivatives, their pharmaceutical...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.